Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2009-12-31 | 2010-12-31 | |
| Income Statement | ||||||
| Revenue | -- | -- | -- | $14.3B | $14.7B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | $1.9B | $1.9B | |
| EBITDA | -- | -- | -- | $2.3B | $2.2B | |
| Diluted EPS | -- | -- | -- | $0.43 | $0.46 | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $20.7B | $24.2B | $22.1B | $21.7B | $22.5B | |
| Total Assets | $84B | $88.7B | $85.2B | $85.6B | $89.1B | |
| Current Liabilities | $28.3B | $30.2B | $27.8B | $28B | $29.4B | |
| Total Liabilities | $60.8B | $64.8B | $61.4B | $60.9B | $65.7B | |
| Total Equity | $23.2B | $23.9B | $23.8B | $24.7B | $23.4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2008-12-31 | 2009-12-31 | 2010-12-31 | 2009-12-31 | 2010-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | $2.6B | $2.3B | |
| Cash From Investing | -- | -- | -- | -$454M | -$1.7B | |
| Cash From Financing | -- | -- | -- | -$2.4B | -$2.9B | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
Unilever Plc engages in the manufacture and sale of consumer goods. It operates through the following segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment offers hair care, skin care, and prestige beauty and health & wellbeing. The Personal Care segment consists of sales of skin cleansing, deodorant, and oral care products. The Home Care segment comprises of sales of fabric care and a wide range of cleaning products. The Nutrition segment refers to sales of scratch cooking aids, dressings, and tea products. The Ice Cream segment covers primarily ice cream products. The company was founded by Antonius Johannes Jurgens, Samuel van den Bergh, and William Hulme Lever in 1930 and is headquartered in London, the United Kingdom.
In the current month, UL has received 3 Buy ratings 0 Hold ratings, and 0 Sell ratings. The UL average analyst price target in the past 3 months is $71.45.
According to analysts, the consensus estimate is that Unilever Plc share price will rise to $71.45 per share over the next 12 months.
Analysts are divided on their view about Unilever Plc share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Unilever Plc is a Sell and believe this share price will drop from its current level to $60.17.
The price target for Unilever Plc over the next 1-year time period is forecast to be $71.45 according to 3 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Unilever Plc is a Buy. 3 of 3 analysts rate the stock a Buy at this time.
You can purchase shares of Unilever Plc via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Unilever Plc shares.
Unilever Plc was last trading at $65.99 per share. This represents the most recent stock quote for Unilever Plc. Yesterday, Unilever Plc closed at $65.73 per share.
In order to purchase Unilever Plc stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 37x
Market Cap: $3.8T
P/E Ratio: 39x
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.